Estimaciones de analistas de Wall Street para PureTech Health plc (PRTC): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-08-27 | $-1.16 | ||
| 2026-04-29 | $-26.90 | $-1.94 | -1286.6% |
| 2025-08-28 | $-1.90 | $-2.04 | +6.9% |
| 2025-04-30 | $3.60 | $-2.83 | +227.2% |
| 2024-08-28 | $-1.50 | $-3.03 | +50.5% |
| 2024-04-25 | $-1.50 | $-3.25 | +53.8% |
| 2023-08-29 | $-0.90 | $-0.03 | -2900.0% |
| 2023-04-28 | $-0.78 | $0.34 | -329.4% |
Ratios de valoración
| Precio / Valor contable | 0.13 |
| EV / EBITDA | -42.07 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $4.4M | $650000 | $16.4M | $8.7M | $8.3M | $10.0M | $2.1M | $3.3M | $4.8M | $4.7M |
| Coste de Ventas | $1.6M | $71.0M | $77.4M | $85.8M | 0 | $110.5M | $152.4M | $4.9M | $3.6M | 0 |
| Beneficio Bruto | $2.9M | -$70.4M | -$61.0M | -$77.2M | $8.3M | -$100.5M | -$136.8M | -$1.6M | $1.3M | $4.7M |
| I+D | $41.2M | $71.7M | $57.3M | $65.2M | $61.2M | $81.5M | $116.1M | $96.2M | $54.3M | $45.7M |
| Generales y Administrativos | $37.2M | $46.3M | $24.4M | $34.9M | $26.5M | $30.8M | $35.7M | $48.4M | $27.5M | $20.7M |
| Gastos Operativos | $78.4M | $116.1M | $120.4M | $144.1M | $127.9M | $160.3M | $61.0M | $54.6M | $140.4M | $103.2M |
| Beneficio Operativo | -$73.9M | -$115.4M | -$104.0M | -$135.4M | -$119.5M | -$150.3M | -$197.8M | -$146.2M | -$136.1M | -$98.5M |
| EBITDA | -$74.8M | -$40.8M | -$65.3M | $487.8M | $62.7M | $26.7M | -$188.9M | -$11.6M | $37.4M | -$61.8M |
| Gastos por Intereses | $6.8M | $10.2M | $14.8M | $4.1M | $2.9M | $4.7M | $4.0M | $13.5M | $10.0M | $45.8M |
| Beneficio Antes de Impuestos | -$83.2M | -$70.7M | -$68.4M | $478.5M | $19.0M | -$59.0M | -$92.8M | -$36.1M | $23.8M | -$110.9M |
| Impuestos | -$1.6M | -$14000 | $2.2M | $112.4M | $14.4M | $3.8M | -$55.7M | $30.5M | -$4.0M | -$842000 |
| Beneficio Neto | -$48.8M | $30.9M | -$43.7M | $421.1M | $6.0M | -$60.6M | -$50.4M | -$65.7M | $53.5M | -$109.7M |
| BPA | $-2.10 | $1.10 | $-1.60 | $14.40 | $0.20 | $-2.10 | $-1.80 | $-2.40 | $2.00 | $-46.00 |
| BPA Diluido | $-2.10 | $1.10 | $-1.60 | $14.40 | $0.20 | $-2.10 | $-1.80 | $-2.40 | $2.00 | $-46.00 |
| Acciones en Circulación (Diluidas) | $23.0M | $23.9M | $27.4M | $29.2M | $29.3M | $28.7M | $28.5M | $27.6M | $27.0M | $2.4M |
Precio
| Precio | $17.38 |
| Capitalización | $4.2B |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: CLYM · GNTA · INBX · IVA · KROS · SLN · TARS
Explorar sector: Healthcare · Biotechnology
Más secciones de PRTC: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones